Attendee List released for European Pharmaceutical Pricing and Reimbursement | Network with Ipsen, MSD, Sanofi, GSK, Da Volterra and many more

Top Quote SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on the 5th - 6th October 2015 in London, will address complex market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more. End Quote
  • (1888PressRelease) September 15, 2015 - In just 3 weeks, SMi will open its doors to the 21st annual European Pharmaceutical Pricing & Reimbursement conference. The two-day event will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies with an invaluable insight into the decision making processes and approaches of vital stakeholders . Furthermore, the conference programme will help further your understanding and enable you to develop best practice approaches to complex market access challenges - with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications through case studies presented by GSK, Sanofi, MSD and many more.

    Featured speakers include:
    Leslie Galloway, Chairman, Ethical Medicines Industry Group
    Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
    Janice Haigh, Practice Leader Market Access, Quintiles
    David Watson, Director of Pricing & Reimbursement, ABPI
    Ken Walsh, Head of Emerging Markets Pricing, GSK
    Toros Sahin, Head of Market Access & Health Economics, Sanofi
    Alexander Roediger, Director European Union Affairs, MSD
    Eric Low, CEO, Myeloma UK
    Maggie Dolan, Regional Pharmacy Procurement Specialist, NHS Commercial Solutions

    To view the full speaker line-up and two-day conference programme, visit

    Benefits of attending:
    The impact of Biosimilars and Orphan Drugs on the the market with case studies from MSD and Quintiles
    Tiered pricing options with a case study from GSK
    Case studies in Reforms with Sanofi sharing their recent experience
    New models for European reimbursement
    Health Technology Assessment policies
    Changes in UK P&R policy following the UK elections with presentations from industry bodies such as EMIG and the ABPI

    Plus, don't miss the interactive post-conference workshop on:
    HTA Uncovered
    Workshop Leaders: Anke Van Engen, Principal - Advisory Services & Janice Haigh, Practice Leader - Market Access, Quintiles
    08:30am - 12.30pm | 7th October 2015, London, UK

  • FB Icon Twitter Icon In-Icon
Contact Information
  • Vinh Trinh
  • Smi Group
  • Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
  • SE1 0BS
  • Voice: 44 (0) 20 7827 6140
  • Visit our Site